Myeloid Cells in Glioblastoma Microenvironment
Glioblastoma (GBM) is the most aggressive, malignant primary brain tumor in adults. GBM is notoriously resistant to immunotherapy mainly due to its unique immune microenvironment. High dimensional data analysis reveals the extensive heterogeneity of immune components making up the GBM microenvironme...
Main Authors: | Alessandra De Leo, Alessio Ugolini, Filippo Veglia |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/1/18 |
Similar Items
-
Targeting the myeloid microenvironment in neuroblastoma
by: Marjolein C. Stip, et al.
Published: (2023-12-01) -
Allies or Enemies—The Multifaceted Role of Myeloid Cells in the Tumor Microenvironment
by: Lisa Haas, et al.
Published: (2019-11-01) -
Friends with Benefits: Chemokines, Glioblastoma-Associated Microglia/Macrophages, and Tumor Microenvironment
by: Elena Codrici, et al.
Published: (2022-02-01) -
Combined Effects of Myeloid Cells in the Neuroblastoma Tumor Microenvironment
by: Jennifer Frosch, et al.
Published: (2021-04-01) -
Heterogeneous Myeloid Cells in Tumors
by: Aixia Dou, et al.
Published: (2021-07-01)